NCT04736927View on ClinicalTrials.gov

Drug-drug Interaction Study With GLPG3667 and Midazolam in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

14

Participants

Timeline

Start Date

January 15, 2021

Primary Completion Date

February 25, 2021

Study Completion Date

February 25, 2021

Conditions

Healthy

Interventions

DRUG

GLPG3667

From Day 3 to Day 8, GLPG3667 capsules q.d. orally in fed state.

DRUG

Midazolam

On Day 1 and Day 7 as liquid formulation, orally in fed state.

Trial Locations (1)

NG11 6JS

Quotient Sciences, Nottingham

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Galapagos NV

INDUSTRY